FDA, Endo Pause Bulk Compounding Lawsuit Pending FDA Guidance

Drug Industry Daily
A A
The FDA filed a joint motion with Endo to pause the company’s lawsuit accusing the agency of breaking the law with its decree authorizing bulk compounding of drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily